FibroGen - Articles and news items

Astellas logo

First patients enrolled into European Phase III programme for potential first in class oral treatment for anaemia associated with chronic kidney disease

Industry news / 18 March 2014 / Astellas

Roxadustat could change treatment of anaemia associated with CKD and remove the need for multiple injections…

AstraZeneca

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+